The inhibition of IL-17, through agents like anti-IL-17 antibodies, has demonstrated protective effects in experimental models of ALI, reducing inflammation, oxidative stress, and tissue remodeling [13,72]. Here, IL17A is linked to acute respiratory distress syndrome.